Convergent evidence from microdialysis and presynaptic immunolabeling for the regulation of γ-aminobutyric acid release in the globus pallidus following acute clozapine or haloperidol administration in rats

Journal of Neurochemistry

Volumn 82, Issue 1, 2002, Pages 172-180

  See, Ronald E ^a   Berglind, William J ^a   Krentz, Lisa ^b   Meshul, Charles K ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antipsychotic; Basal ganglia; Clozapine; GABA; Globus pallidus; Haloperidol

Indexed keywords

4 AMINOBUTYRIC ACID; CLOZAPINE; HALOPERIDOL;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN REGION; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; GABAERGIC SYSTEM; GLOBUS PALLIDUS; HEMISPHERE; MICRODIALYSIS; MOTOR DYSFUNCTION; NERVE PROJECTION; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SUBSTANTIA NIGRA;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOZAPINE; DOPAMINE ANTAGONISTS; EXTRACELLULAR SPACE; FEMALE; FORELIMB; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; HALOPERIDOL; HINDLIMB; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; MICRODIALYSIS; MOTOR ACTIVITY; NEURAL INHIBITION; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0036310492     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00974.x     Document Type: Article

References (52)

1. Serotonin receptors as targets of antipsychotic drugs
2. Oral dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid
3. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence
4. Kinetic differences between synaptic and extrasynaptic GABA(A) receptors in CA1 pyramidal cells
5. Simultaneous determination of basal and evoked output levels of aspartate, glutamate, taurine and 4-aminobutyric acid during microdialysis and from superfused brain slices
6. Synaptic organisation of the basal ganglia
7. The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: An in vivo microdialysis study
8. Decreased mu-opioid receptor binding in the globus pallidus of rats treated with chronic haloperidol
9. Norepinephrine and schizophrenia: A new hypothesis for antipsychotic drug action
10. Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity
11. Methamphetamine alters presynaptic glutamate immunoreactivity in the caudate nucleus and motor cortex
12. Extracellular gamma-aminobutyric acid levels in the rat caudate-putamen: Monitoring the neuronal and glial contribution by intracerebral microdialysis
13. Differential effects of unique profile antipsychotic drugs on extracellular amino acids in the ventral pallidum and globus pallidus of rats
14. Basal ganglia and movement disorders: An update
15. The Paw test: An animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism
16. The role of serotonin receptor subtypes in the behavioural effects of neuroleptic drugs. A paw test study in rats
17. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects
18. Chronic haloperidol-induced alterations in pallidal GABA and striatal D (1)-mediated dopamine turnover as measured by dual probe microdialysis in rats
19. An animal model for coexisting tardive dyskinesia and tardive parkinsonism: A glutamate hypothesis for tardive dyskinesia
20. Neurotransmitters in the human and nonhuman primate basal ganglia
21. On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis
22. Does fast dissociation from the dopamine D(2) receptor explain the action of atypical antipsychotics?: A new hypothesis
23. Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors
24. Activation of muscarinic receptors stimulates GABA release in the rat globus pallidus
25. 6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons
26. Subtype specificity of gamma-aminobutyric acid type A receptor antagonism by clozapine
27. Atypical antipsychotics block the excitatory effects of serotonin in septohippocampal neurons in the rat
28. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus
29. Dopamine D2 receptor control of pallidal fos expression: Comparisons between intact and 6-hydroxydopamine-treated hemispheres
30. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis
31. Clozapine and haloperidol have differential effects on glutamic acid decarboxylase mRNA in the pallidal nuclei of the rat
32. Haloperidol-induced morphological changes in striatum are associated with glutamate synapses
33. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion
34. Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain
35. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum
36. Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6- hydroxydopamine-lesioned rats: A microdialysis study
37. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry
38. Techniques to optimize post-embedding single and double staining for amino acid neurotransmitters
39. The behavioural effects of manipulating GABA function in the globus pallidus
40. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons
41. Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: An intracerebral microdialysis study of gamma-aminobutyric acid in the lateral segment of the globus pallidus
42. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: A microdialysis study in freely moving rats
43. Localized changes in GABA receptor-gated chloride channel in rat brain after long-term haloperidol: Relation to vacuous chewing movements
44. GABA in the striatonigral and striatopallidal systems as moderator and mediator of striatal functions
45. Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia
46. The role of neurotransmitter receptors in the adverse effects of antipsychotic drugs
47. Decreased pallidal GABA following reverse microdialysis with clozapine, but not haloperidol
48. Clozapine and several other antipsychotic/antidepressant drugs preferentially block the same 'core' fraction of GABA (A) receptors
49. Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux
50. Characterization of typical and atypical antipsychotic drags drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors
51. The relationship between hindlimb disturbances, forelimb disturbances and catalepsy after increasing doses of muscimol injected into the striatal-pallidal complexi